24/09/2018 17:44:17

FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In GDS Holdings Limited (Nasdaq: GDS) To Contact The Firm

STEVENSON, Md., Sept. 24, 2018 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of GDS Holdings Limited (Nasdaq: GDS) (“GDS” or the “Company”) American Depositary Shares (ADSs) during the period between November 2, 2016 and July 31, 2018, inclusive (the “Class Period”).  Investors who wish to become proactively involved in the litigation have until October 1, 2018 to seek appointment as lead plaintiff.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court.  The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action.  The lead plaintiff will be selected from among applicants claiming the largest loss from investment in GDS securities during the Class Period.  Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.  No class has yet been certified in the above action.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the Company had overstated its utilization and occupancy rates, that it made acquisitions with related parties at inflated prices, that it used suspect capital and debt raisings despite large off-shore cash reserves, and that it adopted unorthodox accounts receivable and payable practices.

According to the complaint, following a July 31, 2018 report that GDS is borrowing crippling amounts of debt to enrich insiders by acquiring data centers from undisclosed related parties which are not nearly as valuable as the Company claims, and that unrelated data center operators are selling a substantial amount of empty cabinet space in a building which is supposedly exclusively operated and 94% utilized by GDS, the value of GDS shares declined significantly.

If you have suffered a loss in excess of $100,000 from investment in GDS securities purchased on or after November 2, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please contact Brower Piven either by email at hoffman@browerpiven.com or by telephone at (410) 415-6616.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.  If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice.  You need take no action at this time to be a member of the class.

CONTACT:  Charles J. Piven

Brower Piven, A Professional Corporation

1925 Old Valley Road

Stevenson, Maryland 21153

Telephone: 410-415-6616

hoffman@browerpiven.com

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
07 Dec
VELO
Nedenfor vil jeg give et overblik over hvorfor jer er aktionær. Jeg tager måske fejl med mine antage..
38
07 Dec
VELO
CANADA godkendelse (ENDO)   Jeg lovede i en tråd for 2 uger siden at undersøge hvornår vi kan forven..
36
06 Dec
SAS-DKK
SAS aktien har fået kursklø efter et flot og fornemt regnskab, ledelsen vil ikke give budget for reg..
32
08 Dec
VELO
Havde igår en lang snak med min kapitalforvalter emnet - hvordan er det gået Hr og Fru Danmark's por..
27
06 Dec
VELO
  Man kan ikke være i tvivl om formålet med nyt afsnit, samt formuleringen i overskriften, når man s..
16
10 Dec
I:DAX
Det der foregår har da absolut intet med et flash crash at gøre ! Lad dog være med at brug fine bete..
15
10 Dec
 
Klart, klart... et firma, der reklamerer må være desperat. Personligt synes jeg ikke Pandora har n..
15
10 Dec
VELO
Når man følger Veloxis-debatten, og det hr jeg gjort i mange, mange år - også da den hed LCP, så går..
14
05 Dec
DANSKE
Danske bank er ikke mere kriminel end en politibetjent der ikke anholder en butikstyv.
14
06 Dec
 
Dette er hvad jeg kan læse, inden betalingsmuren sænker sig: Berlingske Media skruer op for ambition..
13

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinson’s Disease
2
Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea
3
Uptick Newswire’s Stock Day Podcast Hosts Medifocus, Inc.’s CEO to Discuss Their Minimally Invasive Breakthrough Treatments for Prostate and Breast Cancers
4
WISeKey Secures Printer Systems, from Cartridge to Cloud, with WISePrint@Cloud
5
Flame Seal Products FS-PG Wildfire Protection System Proves Totally Effective in Raging California Wildfire

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
11 December 2018 03:14:53
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB2 - 2018-12-11 04:14:53 - 2018-12-11 03:14:53 - 1000 - Website: OKAY